应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SONN Sonnet BioTherapeutics Holdings, Inc.
休市中 12-20 15:59:59 EST
1.56
-0.03
-1.89%
盘后
1.56
+0.00
0.00%
18:01 EST
最高
1.70
最低
1.55
成交量
23.32万
今开
1.60
昨收
1.59
日振幅
9.43%
总市值
469.16万
流通市值
462.10万
总股本
300.74万
成交额
37.36万
换手率
7.87%
流通股本
296.22万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速上涨5.03%
市场透视 · 12-20 22:42
Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速上涨5.03%
Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘快速拉升8.07%
市场透视 · 12-19
Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘快速拉升8.07%
Sonnet Biotherapeutics Holdings, Inc.2024财年实现净利润-7.44百万美元,同比增加60.49%
市场透视 · 12-18
Sonnet Biotherapeutics Holdings, Inc.2024财年实现净利润-7.44百万美元,同比增加60.49%
Sonnet Biotherapeutics Holdings, Inc.盘中异动 大幅上涨5.69%
市场透视 · 12-18
Sonnet Biotherapeutics Holdings, Inc.盘中异动 大幅上涨5.69%
Sonnet Biotherapeutics Holdings Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要
路透中文 · 12-17
Sonnet Biotherapeutics Holdings Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要
Sonnet BioTherapeutics 2024财年GAAP每股收益$(11.35)
财报速递 · 12-17
Sonnet BioTherapeutics 2024财年GAAP每股收益$(11.35)
Sonnet Biotherapeutics Holdings Inc 预计每股亏损 5.52 美元 - 财报前瞻
Reuters · 12-14
Sonnet Biotherapeutics Holdings Inc 预计每股亏损 5.52 美元 - 财报前瞻
Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘股价大跌5.73%报1.80美元
市场透视 · 12-12
Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘股价大跌5.73%报1.80美元
Sonnet Biotherapeutics Holdings Inc 预计每股亏损 5.52 美元 - 财报前瞻
路透中文 · 12-11
Sonnet Biotherapeutics Holdings Inc 预计每股亏损 5.52 美元 - 财报前瞻
Sonnet Biotherapeutics Holdings, Inc.股价飙升105.71% 市值涨382.56万美元
市场透视 · 12-09
Sonnet Biotherapeutics Holdings, Inc.股价飙升105.71% 市值涨382.56万美元
Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速拉升5.26%
市场透视 · 12-06
Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速拉升5.26%
Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大跌6.44%
市场透视 · 12-06
Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大跌6.44%
Sonnet Biotherapeutics Holdings, Inc.盘中异动 临近午盘急速跳水5.49%报2.47美元
市场透视 · 12-04
Sonnet Biotherapeutics Holdings, Inc.盘中异动 临近午盘急速跳水5.49%报2.47美元
Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大跌5.42%报2.62美元
市场透视 · 11-28
Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大跌5.42%报2.62美元
Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速跳水5.03%报2.83美元
市场透视 · 11-25
Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速跳水5.03%报2.83美元
Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大涨5.47%报3.08美元
市场透视 · 11-22
Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大涨5.47%报3.08美元
Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘大幅上涨5.12%
市场透视 · 11-21
Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘大幅上涨5.12%
Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘股价大涨8.07%
市场透视 · 11-19
Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘股价大涨8.07%
Sonnet Biotherapeutics Holdings, Inc.盘中异动 下午盘股价大涨5.96%报3.20美元
市场透视 · 11-19
Sonnet Biotherapeutics Holdings, Inc.盘中异动 下午盘股价大涨5.96%报3.20美元
Sonnet Biotherapeutics Holdings, Inc.盘中异动 大幅上涨5.50%
市场透视 · 11-16
Sonnet Biotherapeutics Holdings, Inc.盘中异动 大幅上涨5.50%
公司概况
公司名称:
Sonnet BioTherapeutics Holdings, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Sonnet BioTherapeutics Holdings, Inc.于1999年10月21日根据特拉华州法律成立。该公司是一家临床生物制药公司,拥有开发新型生物药物的专利技术,称为FHAB(完全人白蛋白结合体)。FHAB利用全人源单链抗体片段(scFv),与一种或两种治疗分子连接,能够影响单一或双特异性的作用机制。FHAB结构包含一个设计用于与人血清白蛋白(HSA)结合并“搭便车”的结构域,以便运输到实体肿瘤或淋巴系统等目标。该公司设计了这种结构,以促进药物在特定组织中的积累,并延长体内活性的持续时间。FHAB发展候选细胞在哺乳动物细胞培养中产生,使糖基化,从而降低免疫原性的风险。该公司的FHAB技术非常适合未来人类疾病领域的药物开发,包括肿瘤学、自身免疫、病原学、炎症和血液学疾病。
发行价格:
--
{"stockData":{"symbol":"SONN","market":"US","secType":"STK","nameCN":"Sonnet BioTherapeutics Holdings, Inc.","latestPrice":1.56,"timestamp":1734728399999,"preClose":1.59,"halted":0,"volume":233235,"hourTrading":{"tag":"盘后","latestPrice":1.56,"preClose":1.56,"latestTime":"18:01 EST","volume":147,"amount":229.69,"timestamp":1734735688309},"delay":0,"floatShares":2962200,"shares":3007431,"eps":-16.809072,"marketStatus":"休市中","marketStatusCode":7,"change":-0.03,"latestTime":"12-20 15:59:59 EST","open":1.6,"high":1.7,"low":1.55,"amount":373648.977256,"amplitude":0.09434,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-16.809072,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"adjPreClose":1.59,"preHourTrading":{"tag":"盘前","latestPrice":1.63,"preClose":1.59,"latestTime":"09:25 EST","volume":638,"amount":1012.350009,"timestamp":1734704737731},"postHourTrading":{"tag":"盘后","latestPrice":1.56,"preClose":1.56,"latestTime":"18:01 EST","volume":147,"amount":229.69,"timestamp":1734735688309},"volumeRatio":0.8723865992800525},"requestUrl":"/m/hq/s/SONN/wiki","defaultTab":"wiki","newsList":[{"id":"2493257954","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493257954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493257954?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:42","pubTimestamp":1734705775,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时42分,Sonnet Biotherapeutics Holdings, Inc.股票出现波动,股价急速拉升5.03%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,Humacyte, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大,Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃,换手率分别为1920.56%、88.07%、55.68%,振幅较大的相关个股有Humacyte, Inc.、Aptose Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 ,振幅分别为35.26%、34.90%、34.80%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220224255ab876a13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220224255ab876a13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SONN"],"gpt_icon":0},{"id":"2492717271","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘快速拉升8.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492717271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492717271?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:34","pubTimestamp":1734618877,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时34分,Sonnet Biotherapeutics Holdings, Inc.股票出现异动,股价急速上涨8.07%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体跌幅为2.54%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Abpro Holdings Inc C/Wts 12/11/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Phio Pharmaceuticals Corp.、Psyence Biomedical Ltd.、Elevai Labs, Inc.较为活跃,换手率分别为408.50%、320.93%、316.09%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Oragenics Inc.,振幅分别为92.86%、25.58%、20.92%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223438ab849f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223438ab849f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2492841180","title":"Sonnet Biotherapeutics Holdings, Inc.2024财年实现净利润-7.44百万美元,同比增加60.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492841180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492841180?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:00","pubTimestamp":1734534011,"startTime":"0","endTime":"0","summary":"12月18日,Sonnet Biotherapeutics Holdings, Inc.公布财报,公告显示公司2024财年净利润为-7.44百万美元,同比增加60.49%;其中营业收入为18626.00美元,同比减少87.40%,每股基本收益为-11.35美元。从资产负债表来看,Sonnet Biotherapeutics Holdings, Inc.总负债3.26百万美元,其中短期债务84291.00美元,资产负债比为0.85,流动比率为0.67。机构评级:截至2024年12月18日,当前有1家机构对Sonnet Biotherapeutics Holdings, Inc.目标价做出预测,其中目标均价为240.00美元,其中最低目标价为240.00美元,最高目标价为240.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218230018ab8213f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218230018ab8213f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN"],"gpt_icon":0},{"id":"2492218152","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 大幅上涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492218152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492218152?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:34","pubTimestamp":1734532492,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时34分,Sonnet Biotherapeutics Holdings, Inc.股票出现波动,股价大幅拉升5.69%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,Cognition Therapeutics, Inc.、Tc Biopharm Plc、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Cognition Therapeutics, Inc.、Tc Biopharm Plc、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为312.98%、245.68%、92.01%,振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Tc Biopharm Plc,振幅分别为66.83%、48.36%、30.17%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223452984cb275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223452984cb275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4139","SONN","BK4007"],"gpt_icon":0},{"id":"2492963889","title":"Sonnet Biotherapeutics Holdings Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2492963889","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492963889?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:28","pubTimestamp":1734445690,"startTime":"0","endTime":"0","summary":"Sonnet Biotherapeutics Holdings Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Sonnet Biotherapeutics Holdings Inc SONN.OQ报告了截至9月30日的季度调整后每股亏损3.83美元,高于去年同期的每股收益16.72美元。Sonnet Biotherapeutics Holdings Inc 报告的本季度每股收益为亏损 3.83 美元。Sonnet Biotherapeutics Holdings Inc 的股价本季度下跌了 72.9%,今年迄今为止下跌了 87.0%。华尔街对 Sonnet Biotherapeutics Holdings Inc 的 12 个月目标价中位数为 240.00 美元。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4S3NI106:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"1134618034","title":"Sonnet BioTherapeutics 2024财年GAAP每股收益$(11.35)","url":"https://stock-news.laohu8.com/highlight/detail?id=1134618034","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134618034?lang=zh_cn&edition=full","pubTime":"2024-12-17 21:54","pubTimestamp":1734443659,"startTime":"0","endTime":"0","summary":"Sonnet BioTherapeutics (NASDAQ:SONN)公布2024财年每股季度亏损$(11.35)。以上内容来自Benzinga Earnings专栏,原文如下:Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(11.35) per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Sonnet BioTherapeutics 2024财年GAAP每股收益$(11.35)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SONN"],"gpt_icon":0},{"id":"2491583815","title":"Sonnet Biotherapeutics Holdings Inc 预计每股亏损 5.52 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2491583815","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491583815?lang=zh_cn&edition=full","pubTime":"2024-12-14 05:03","pubTimestamp":1734123806,"startTime":"0","endTime":"0","summary":" * Sonnet Biotherapeutics Holdings Inc 将于12月16日公布截至2024年9月30日的财报,预计季度收入将下降()。* * LSEG的分析师平均预计Sonnet Biotherapeutics Holdings Inc每股亏损5.52美元。* 分析师对该公司股票的评级为 \"买入\"。* 在过去三个月中,分析师的平均盈利预期保持不变。* 华尔街对 Sonnet Biotherapeutics Holdings Inc 的 12 个月目标价中位数为 240.00 美元,高于其上一次收盘价 1.77 美元。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Sonnet Biotherapeutics Holdings Inc 预计每股亏损 5.52 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SONN"],"gpt_icon":0},{"id":"2490594384","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘股价大跌5.73%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490594384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490594384?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:31","pubTimestamp":1734013884,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时31分,Sonnet Biotherapeutics Holdings, Inc.股票出现波动,股价急速下跌5.73%。截至发稿,该股报1.80美元/股,成交量3.9307万股,换手率1.53%,振幅5.76%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。其相关个股中,Palisade Bio, Inc.、Trevi Therapeutics, Inc.、Aptevo Therapeutics Inc.涨幅较大,Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为1837.70%、411.21%、49.08%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Os Therapies Incorporated、Entero Therapeutics Inc.,振幅分别为11.49%、10.63%、9.76%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223125a1e95053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223125a1e95053&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SONN"],"gpt_icon":0},{"id":"2490026641","title":"Sonnet Biotherapeutics Holdings Inc 预计每股亏损 5.52 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2490026641","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490026641?lang=zh_cn&edition=full","pubTime":"2024-12-11 05:02","pubTimestamp":1733864544,"startTime":"0","endTime":"0","summary":"Sonnet Biotherapeutics Holdings Inc 预计每股亏损 5.52 美元 - 财报前瞻Sonnet Biotherapeutics Holdings Inc SONN.OQ SONN.O将于12月12日公布截至2024年9月30日的财报() 预计季度收入将出现下降。LSEG的分析师平均预计Sonnet Biotherapeutics Holdings Inc每股亏损5.52美元。华尔街对 Sonnet Biotherapeutics Holdings Inc 的 12 个月目标价中位数为 240.00 美元,高于其上一次收盘价 1.98 美元。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL4S3NB1NF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SONN"],"gpt_icon":0},{"id":"2490080776","title":"Sonnet Biotherapeutics Holdings, Inc.股价飙升105.71% 市值涨382.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490080776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490080776?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:31","pubTimestamp":1733754698,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时31分,Sonnet Biotherapeutics Holdings, Inc.股票出现波动,股价大幅拉升105.71%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Metagenomi, Inc.涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为2069.64%、23.55%、18.73%,振幅较大的相关个股有Tnf Pharmaceuticals, Inc.、Alector, Inc.、Vor Biopharma Inc.,振幅分别为111.17%、107.41%、107.37%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223138ab6a0980&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223138ab6a0980&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2489369452","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489369452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489369452?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:33","pubTimestamp":1733495636,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时33分,Sonnet Biotherapeutics Holdings, Inc.股票出现波动,股价急速上涨5.26%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Cardio Diagnostics Holdings Inc.、Exicure, Inc.涨幅较大,Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为23.82%、21.44%、12.03%,振幅较大的相关个股有Reviva Pharmaceuticals Holdings, Inc.、Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.,振幅分别为11.66%、11.18%、10.92%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622335698e5e198&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622335698e5e198&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SONN"],"gpt_icon":0},{"id":"2489467220","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大跌6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489467220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489467220?lang=zh_cn&edition=full","pubTime":"2024-12-06 01:03","pubTimestamp":1733418226,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日01时03分,Sonnet Biotherapeutics Holdings, Inc.股票出现异动,股价快速下挫6.44%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Molecular Templates, Inc.涨幅较大,Molecular Templates, Inc.、Psyence Biomedical Ltd.、Protara Therapeutics, Inc.较为活跃,换手率分别为3246.20%、2318.50%、457.40%,振幅较大的相关个股有Molecular Templates, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.,振幅分别为124.83%、120.00%、106.21%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206010346ab6044b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206010346ab6044b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SONN"],"gpt_icon":0},{"id":"2488289749","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 临近午盘急速跳水5.49%报2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488289749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488289749?lang=zh_cn&edition=full","pubTime":"2024-12-04 00:38","pubTimestamp":1733243896,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日00时38分,Sonnet Biotherapeutics Holdings, Inc.股票出现异动,股价大幅跳水5.49%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Janux Therapeutics, Inc.涨幅较大,Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃,换手率分别为145.00%、123.13%、117.54%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为69.23%、59.76%、51.13%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120400381698e52163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120400381698e52163&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2486805875","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大跌5.42%报2.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486805875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486805875?lang=zh_cn&edition=full","pubTime":"2024-11-28 02:40","pubTimestamp":1732732826,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日02时40分,Sonnet Biotherapeutics Holdings, Inc.股票出现波动,股价大幅下挫5.42%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1010.65%、246.77%、54.45%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Protagenic Therapeutics Inc C/Wts 29/04/2026 ,振幅分别为86.60%、79.26%、78.75%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112802402698e44fe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112802402698e44fe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2486103113","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 急速跳水5.03%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486103113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486103113?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:49","pubTimestamp":1732549782,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时49分,Sonnet Biotherapeutics Holdings, Inc.股票出现异动,股价快速下跌5.03%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体涨幅为2.07%。其相关个股中,Alpha Tau Medical Ltd C/Wts 、Apollomics Inc C/Wts 01/04/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,木薯科学、Cognition Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为111.18%、101.54%、59.93%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为89.11%、78.65%、65.85%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234942a254b33e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234942a254b33e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2485988419","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 股价大涨5.47%报3.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485988419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485988419?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:07","pubTimestamp":1732205234,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时07分,Sonnet Biotherapeutics Holdings, Inc.股票出现异动,股价急速拉升5.47%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Conduit Pharmaceuticals Inc.、Biodexa Pharmaceuticals Plc、Tff Pharmaceuticals, Inc.较为活跃,换手率分别为475.18%、428.51%、102.96%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为162.20%、81.04%、76.33%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112200071498e43f7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112200071498e43f7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2485149446","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘大幅上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485149446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485149446?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:00","pubTimestamp":1732118450,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时00分,Sonnet Biotherapeutics Holdings, Inc.股票出现异动,股价快速上涨5.12%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。其相关个股中,Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为1148.14%、981.83%、251.43%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为183.66%、169.09%、73.14%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000050a248ed8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000050a248ed8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2484929702","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 早盘股价大涨8.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484929702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484929702?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:31","pubTimestamp":1732030297,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时31分,Sonnet Biotherapeutics Holdings, Inc.股票出现异动,股价大幅拉升8.07%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体跌幅为1.12%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大,Tff Pharmaceuticals, Inc.、Exicure, Inc.、Hcw Biologics Inc.较为活跃,换手率分别为706.23%、106.58%、101.70%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为81.67%、62.18%、52.14%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119233137abcf85a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119233137abcf85a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2484604192","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 下午盘股价大涨5.96%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484604192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484604192?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:14","pubTimestamp":1731953679,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时14分,Sonnet Biotherapeutics Holdings, Inc.股票出现波动,股价急速拉升5.96%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Hcw Biologics Inc.、冠科美博、Tharimmune, Inc.较为活跃,换手率分别为1155.78%、1072.64%、566.75%,振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为563.48%、211.37%、193.44%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111902144098e43529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111902144098e43529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0},{"id":"2483302409","title":"Sonnet Biotherapeutics Holdings, Inc.盘中异动 大幅上涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483302409","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483302409?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:59","pubTimestamp":1731689940,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时59分,Sonnet Biotherapeutics Holdings, Inc.股票出现异动,股价快速上涨5.50%。Sonnet Biotherapeutics Holdings, Inc.股票所在的生物技术行业中,整体跌幅为3.60%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings, Inc.涨幅较大,Tc Biopharm Plc、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为4338.66%、647.38%、471.77%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 ,振幅分别为134.58%、129.73%、110.59%。Sonnet Biotherapeutics Holdings, Inc.公司简介:Sonnet BioTherapeutics Holdings Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116005900971a6eb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116005900971a6eb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SONN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sonnetbio.com","stockEarnings":[{"period":"1week","weight":-0.1381},{"period":"1month","weight":-0.4658},{"period":"3month","weight":-0.805},{"period":"6month","weight":-0.801},{"period":"1year","weight":-0.8952},{"period":"ytd","weight":-0.8879}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sonnet BioTherapeutics Holdings, Inc.于1999年10月21日根据特拉华州法律成立。该公司是一家临床生物制药公司,拥有开发新型生物药物的专利技术,称为FHAB(完全人白蛋白结合体)。FHAB利用全人源单链抗体片段(scFv),与一种或两种治疗分子连接,能够影响单一或双特异性的作用机制。FHAB结构包含一个设计用于与人血清白蛋白(HSA)结合并“搭便车”的结构域,以便运输到实体肿瘤或淋巴系统等目标。该公司设计了这种结构,以促进药物在特定组织中的积累,并延长体内活性的持续时间。FHAB发展候选细胞在哺乳动物细胞培养中产生,使糖基化,从而降低免疫原性的风险。该公司的FHAB技术非常适合未来人类疾病领域的药物开发,包括肿瘤学、自身免疫、病原学、炎症和血液学疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.003533},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.021578},{"month":3,"riseRate":0.25,"avgChangeRate":-0.051231},{"month":4,"riseRate":0.25,"avgChangeRate":-0.107955},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.027445},{"month":6,"riseRate":0.5,"avgChangeRate":-0.023052},{"month":7,"riseRate":0.153846,"avgChangeRate":-0.08803},{"month":8,"riseRate":0.076923,"avgChangeRate":-0.179917},{"month":9,"riseRate":0.461538,"avgChangeRate":-0.022377},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.09568},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.066992},{"month":12,"riseRate":0.25,"avgChangeRate":-0.077102}],"exchange":"NASDAQ","name":"Sonnet BioTherapeutics Holdings, Inc.","nameEN":"Sonnet BioTherapeutics Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sonnet BioTherapeutics Holdings, Inc.(SONN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sonnet BioTherapeutics Holdings, Inc.(SONN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sonnet BioTherapeutics Holdings, Inc.,SONN,Sonnet BioTherapeutics Holdings, Inc.股票,Sonnet BioTherapeutics Holdings, Inc.股票老虎,Sonnet BioTherapeutics Holdings, Inc.股票老虎国际,Sonnet BioTherapeutics Holdings, Inc.行情,Sonnet BioTherapeutics Holdings, Inc.股票行情,Sonnet BioTherapeutics Holdings, Inc.股价,Sonnet BioTherapeutics Holdings, Inc.股市,Sonnet BioTherapeutics Holdings, Inc.股票价格,Sonnet BioTherapeutics Holdings, Inc.股票交易,Sonnet BioTherapeutics Holdings, Inc.股票购买,Sonnet BioTherapeutics Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sonnet BioTherapeutics Holdings, Inc.(SONN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sonnet BioTherapeutics Holdings, Inc.(SONN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}